...
首页> 外文期刊>Journal of women’s health >Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities.
【24h】

Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities.

机译:自我收集的人乳头瘤病毒测试的可接受性:两种自我采样方式的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Human papillomavirus (HPV) testing can be used as a primary test for cervical cancer screening. HPV self-sampling has the potential to replace physicianurse sampling. Our objective was to compare the acceptability of two self-sampling methods among 205 women undergoing an excisional procedure for cervical intraepithelial neoplasia (CIN) at the European Institute of Oncology (IEO). METHODS: One hundred eleven patients were given a Hybrid Capture (HC) Cervical Sampler (Qiagen, Hilden, Germany), and 94 received a self-lavaging device, the Delphi(R) Screener (Delphi Bioscience, Scherpenzeel, The Netherlands), both with written instructions. Self-sampling was performed just before the clinician-collected cervical sample. Women responded to questions using 5-point ordinal scales on the general acceptability of self-sampling and the physical comfort, embarrassment, pain, and difficulty experienced. Participants were also asked whether they prefer self-sampling or clinician sampling. RESULTS: Both self-sampling methods were generally accepted with a significantly high score (p = 0.005) and significantly lower embarrassment (p = 0.042) in favor of the Delphi Screener. Both self-sampling methods were physically well accepted, not painful, and easy to perform. Most women (n = 117, 68%) preferred the self-sampled compared to the clinician-sampled test, with a significantly higher proportion in the Delphi Screener group (n = 59, 77.6%) compared to those using the HC Sampler (n = 58, 60.4%) (p = 0.021). CONCLUSIONS: The present study shows that self-sampling for HPV testing is favorably received by women. A sampling device specifically developed for self-sampling, such as the Delphi Screener, shows the highest degree of satisfaction. A well-accepted HPV sampling method could be especially useful for women who do not take part in cervical screening or in settings where organized screening is not fully implemented.
机译:背景:人类乳头瘤病毒(HPV)检测可用作宫颈癌筛查的主要检测方法。 HPV自采样有可能取代医师/护士采样。我们的目的是在欧洲肿瘤研究所(IEO)的205例接受宫颈上皮内瘤变(CIN)切除手术的妇女中比较两种自我取样方法的可接受性。方法:向11例患者提供了混合捕获(HC)宫颈采样器(德国盖尔根,盖恩),其中94例患者接受了自动冲洗装置Delphi®Screener(Delphi Bioscience,Scherpenzeel,荷兰),两者并附有书面指示。在临床医生收集宫颈样本之前就进行了自采样。妇女使用5点序量表回答有关自我采样的一般可接受性以及身体舒适感,尴尬,痛苦和经历的困难的问题。与会者还被问及他们是否更喜欢自我抽样或临床医生抽样。结果:两种自采样方法均被普遍接受,以较高的分数(p = 0.005)和显着降低的尴尬感(p = 0.042)受到了Delphi Screener的支持。两种自采样方法在物理上都是公认的,没有痛苦,并且易于执行。与临床医生抽样测试相比,大多数女性(n = 117,68%)倾向于使用自采样,与使用HC采样器的女性(n = 59,77.6%)相比,在Delphi Screener组中的比例要高得多(n = 59,77.6%)。 = 58,60.4%)(p = 0.021)。结论:本研究表明,HPV检测的自我抽样受到女性的欢迎。专为自采样而开发的采样设备(例如Delphi Screener)显示出最高的满意度。对于不参与子宫颈筛查或未完全实施有组织筛查的女性,一种公认的HPV采样方法可能特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号